US stockmarkets shrug off signs of overheating
Signs of overheating in the markets are everywhere, but that didn't stop US stocks hitting new record highs last week.

The stockmarket “bubble-o-meter is flashing bright red”, says John Authers on Bloomberg. Signs of froth are everywhere, from the record number of fund managers telling a Bank of America survey that they are making risky bets to wild swings in the price of bitcoin, previously a harbinger of market turning points.
Biden goes big
US stocks celebrated Joe Biden’s inauguration as US president last week by hitting new record highs, says Randall Forsyth in Barron’s. The S&P 500 has gained more than 4% since the start of the year. The bull market is riding an optimistic “triumvirate”.
First, monetary policy remains exceptionally supportive: the M2 gauge of the US money supply grew by an annualised 25.1% last month. Second, the vaccine trade is still going strong. But most importantly, third is the new president’s enormous $1.9trn stimulus plan.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
“That’s a lot of money,” says The New York Times. The plan would include direct $1,400 payments to all US households and enhanced unemployment benefits to be funded entirely through extra government borrowing. It is about twice the size of Barack Obama’s post-financial crisis stimulus bill and comes on top of the $2.9trn already spent on Covid-19 relief.
Biden’s plan would end up overheating the economy, says The Economist. The US spent about 14% of its GDP on stimulus last year, more than the likely fall in output caused by the virus. Biden’s plan could see relief spending running at about $300bn a month during the first three quarters of this year, far more than a monthly GDP shortfall of about $80bn. When the pandemic ends and US households deploy their $1.6trn savings pile, there will be too much cash chasing too few goods and services. That said, there is a good chance that Congress will chop the bill down somewhat before it is finally approved.
Economy up, markets down?
It’s a similar story on this side of the pond, says Liam Halligan in The Daily Telegraph. Joe Biden and Boris Johnson might make awkward political bedfellows, but they have at least one thing “in common”: spend, spend, spend. The UK Treasury is also borrowing record amounts – £271bn so far this fiscal year, compared to £60bn at the same time in 2020. Britain’s national debt is going above 100% of GDP, “a first in our peacetime history”. This fiscal and monetary cocktail is likely to drive an economic boom later this year.
But will the stockmarket join in? asks Justin Lahart in The Wall Street Journal. Last year’s brazen gains were a reminder that “the stockmarket’s link to the economy can be as thin as tissue paper”. As big business and tech loses its lockdown edge, could those gains reverse this year?
History shows that “protracted bear markets” rarely happen at the start of a new economic cycle, although there were exceptions in 1980 and 1946. Then again, we haven’t had such a devastating pandemic for 100 years either. Those betting that 2021 will deliver stockmarket nirvana could be making a “costly” mistake.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
How to invest during stagflation
Trump’s tariffs look poised to push the global economy into a period of stagflation. We look at how to ensure your investments can survive a global slowdown.
By Dan McEvoy Published
-
Best-performing funds and investment trusts for stocks and shares ISAs of all time
As ISAs celebrate their 26th birthday, we reveal the best-performing funds and investment trusts since stocks and shares ISAs launched in April 1999, and how much they would be worth today
By Ruth Emery Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves Published